Director/PDMR Shareholding
Stratec Biomedical Systems AG
€40.20
18:34 28/03/24
BP p.l.c.
Notification of transactions of persons discharging managerial responsibility or connected persons
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Bernard Looney | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer / Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | BP p.l.c. | ||||
b) | LEI | 213800LH1BZH3DI6G760 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of $0.25
GB0007980591 | ||||
b) | Nature of the transaction | Shares acquired pursuant to the release of Restricted Share Units under the BP Share Value Plan, following adjustments for tax and dividends. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Volume - Price - Total |
193,700
Nil consideration (market value £4.697)
Nil (market value £909,808.90) | ||||
e) | Date of the transaction | 11 February 2020 | ||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Bernard Looney | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Officer / Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | BP p.l.c. | ||||
b) | LEI | 213800LH1BZH3DI6G760 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of $0.25
GB0007980591 | ||||
b) | Nature of the transaction | Vesting of restricted share units pursuant to the BP Restricted Share Plan II award made in 2018, after adjustment for tax, dividends and expenses. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
- Volume
- Price
- Total |
61,429
Nil consideration (market value £4.697)
Nil (market value £288,532.01)
| ||||
e) | Date of the transaction | 11 February 2020 | ||||
f) | Place of the transaction | Outside a trading venue |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Mehmet Tufan Erginbilgic | ||||
2 | Reason for the notification | |||||
a) | Position/status | Chief Executive Downstream / PDMR | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | BP p.l.c. | ||||
b) | LEI | 213800LH1BZH3DI6G760 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of $0.25
GB0007980591 | ||||
b) | Nature of the transaction | Shares acquired pursuant to the release of restricted share units under the BP Share Value Plan, following adjustments for tax and dividends. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Volume - Price - Total |
252,992
Nil consideration (market value £4.697)
Nil (market value £1,188,303.42) | ||||
e) | Date of the transaction | 11 February 2020 | ||||
f) | Place of the transaction | Outside a trading venue |
This notice is given in fulfilment of the obligation under Article 19 of the Market Abuse Regulation.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.